BNTX

BioNTech SE - American Depositary Shares (BNTX)

About BioNTech SE - American Depositary Shares (BNTX)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Details

Daily high

$98.98

Daily low

$96.61

Price at open

$97.24

52 Week High

$124.00

52 Week Low

$79.52

Market cap

24.1B

Dividend yield

Volume

801,206

Avg. volume

1.1M

P/E ratio

-12.24

BioNTech SE - American Depositary Shares News